Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Adjunctive dabigatran therapy improves outcome of experimental left-sided Staphylococcus aureus endocarditis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Gasotransmitters and the immune system: Mode of action and novel therapeutic targets

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

    Research output: Contribution to journalLetterResearchpeer-review

View graph of relations
Tumour necrosis factor alpha (TNFalpha) neutralising antibody constructs are increasingly being used to treat rheumatoid arthritis (RA).
Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Volume68
Issue number11
Pages (from-to)1739-45
Number of pages7
ISSN0003-4967
DOIs
Publication statusPublished - 1 Nov 2009

ID: 32255533